{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:24:26Z","timestamp":1793899466175,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04039-1","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:15:42Z","timestamp":1741763742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) study"],"prefix":"10.1186","volume":"25","author":[{"given":"Robert E.","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Viktrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Jolanda","family":"Muenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn C.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"4","key":"4039_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from Government Health studies. Headache Apr. 2018;58(4):496\u2013505. https:\/\/doi.org\/10.1111\/head.13281.","journal-title":"Headache Apr"},{"issue":"9859","key":"4039_CR2","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"15","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of Disease Study 2010. Lancet Dec. 2012;15(9859):2163\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(12)61729-2.","journal-title":"Lancet Dec"},{"issue":"10283","key":"4039_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"17","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet Apr. 2021;17(10283):1485\u201395. https:\/\/doi.org\/10.1016\/S0140-6736(20)32160-7.","journal-title":"Lancet Apr"},{"key":"4039_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/B978-0-444-62627-1.00025-1","volume":"131","author":"K Baigi","year":"2015","unstructured":"Baigi K, Stewart WF. Headache and migraine: a leading cause of absenteeism. Handb Clin Neurol. 2015;131:447\u201363. https:\/\/doi.org\/10.1016\/B978-0-444-62627-1.00025-1.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"4039_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/head.12251","volume":"54","author":"GN Ferracini","year":"2014","unstructured":"Ferracini GN, Dach F, Speciali JG. Quality of life and health-related disability in children with migraine. Headache Feb. 2014;54(2):325\u201334. https:\/\/doi.org\/10.1111\/head.12251.","journal-title":"Headache Feb"},{"issue":"1","key":"4039_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-018-0865-z","volume":"24","author":"TJ Schwedt","year":"2018","unstructured":"Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain May. 2018;24(1):38. https:\/\/doi.org\/10.1186\/s10194-018-0865-z.","journal-title":"J Headache Pain May"},{"issue":"1","key":"4039_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-022-00415-0","volume":"2","author":"S Ashina","year":"2023","unstructured":"Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers Feb. 2023;2(1):5. https:\/\/doi.org\/10.1038\/s41572-022-00415-0.","journal-title":"Nat Rev Dis Primers Feb"},{"key":"4039_CR8","doi-asserted-by":"publisher","unstructured":"Buse DC, Rupnow MF, Lipton RB. May. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84(5):422\u2009\u2013\u200935. https:\/\/doi.org\/10.1016\/S0025-6196(11)60561-2","DOI":"10.1016\/S0025-6196(11)60561-2"},{"issue":"15","key":"4039_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/0333102411425960","volume":"31","author":"RP Insinga","year":"2011","unstructured":"Insinga RP, Ng-Mak DS, Hanson ME. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA. Cephalalgia Nov. 2011;31(15):1570\u20135. https:\/\/doi.org\/10.1177\/0333102411425960.","journal-title":"Cephalalgia Nov"},{"issue":"4","key":"4039_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3111\/13696998.2013.770748","volume":"16","author":"RB Lipton","year":"2013","unstructured":"Lipton RB, Buse DC, Saiers J, Serrano D, Reed ML. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. J Med Econ. 2013;16(4):490\u20139. https:\/\/doi.org\/10.3111\/13696998.2013.770748.","journal-title":"J Med Econ"},{"key":"4039_CR11","doi-asserted-by":"publisher","DOI":"10.31235\/osf.io\/7nm9x","author":"RK Best","year":"2022","unstructured":"Best RK, Arseniev-Koehler A. The Stigma of diseases: unequal burden. Uneven Decline. 2022. https:\/\/doi.org\/10.31235\/osf.io\/7nm9x.","journal-title":"Uneven Decline"},{"issue":"1","key":"4039_CR12","doi-asserted-by":"publisher","first-page":"e54074","DOI":"10.1371\/journal.pone.0054074","volume":"8","author":"WB Young","year":"2013","unstructured":"Young WB, Park JE, Tian IX, Kempner J. The stigma of migraine. PLoS ONE. 2013;8(1):e54074. https:\/\/doi.org\/10.1371\/journal.pone.0054074.","journal-title":"PLoS ONE"},{"key":"4039_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-soc-071312-145702","volume":"41","author":"BA Pescosolido","year":"2015","unstructured":"Pescosolido BA, Martin JK. The Stigma Complex. Annu Rev Sociol Aug. 2015;41:87\u2013116. https:\/\/doi.org\/10.1146\/annurev-soc-071312-145702.","journal-title":"Annu Rev Sociol Aug"},{"issue":"11","key":"4039_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11916-021-00982-z","volume":"6","author":"SK Parikh","year":"2021","unstructured":"Parikh SK, Kempner J, Young WB. Stigma and migraine: developing effective interventions. Curr Pain Headache Rep Dec. 2021;6(11):75. https:\/\/doi.org\/10.1007\/s11916-021-00982-z.","journal-title":"Curr Pain Headache Rep Dec"},{"issue":"3","key":"4039_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40120-023-00456-x","volume":"12","author":"E Gross","year":"2023","unstructured":"Gross E, de la Ruiz E, Martelletti P. The Migraine Stigma Kaleidoscope View. Neurol Ther Jun. 2023;12(3):703\u20139. https:\/\/doi.org\/10.1007\/s40120-023-00456-x.","journal-title":"Neurol Ther Jun"},{"issue":"3","key":"4039_CR16","doi-asserted-by":"publisher","first-page":"e208074","DOI":"10.1212\/WNL.0000000000208074","volume":"13","author":"RE Shapiro","year":"2024","unstructured":"Shapiro RE, Nicholson RA, Seng EK, et al. Migraine-related stigma and its relationship to disability, Interictal Burden, and quality of life: results of the OVERCOME (US) Study. Neurol Feb. 2024;13(3):e208074. https:\/\/doi.org\/10.1212\/WNL.0000000000208074.","journal-title":"Neurol Feb"},{"key":"4039_CR17","doi-asserted-by":"publisher","unstructured":"Vilanilam GK, Badi MK, Meschia JF. Destigmatizing Migraine. Cureus. May 30. 2018;10(5):e2711. https:\/\/doi.org\/10.7759\/cureus.2711","DOI":"10.7759\/cureus.2711"},{"issue":"9","key":"4039_CR18","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/pm\/pnaa465","volume":"8","author":"AS Zubair","year":"2021","unstructured":"Zubair AS, Sico JJ, Kuruvilla DE. Presence of Stigma in the treatment of patients with Migraine among neurologists. Pain Med Sep. 2021;8(9):2135\u20138. https:\/\/doi.org\/10.1093\/pm\/pnaa465.","journal-title":"Pain Med Sep"},{"issue":"4","key":"4039_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40122-022-00418-5","volume":"11","author":"F Perugino","year":"2022","unstructured":"Perugino F, De Angelis V, Pompili M, Martelletti P. Stigma and Chronic Pain. Pain Ther Dec. 2022;11(4):1085\u201394. https:\/\/doi.org\/10.1007\/s40122-022-00418-5.","journal-title":"Pain Ther Dec"},{"issue":"2","key":"4039_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, et al. Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache Feb. 2022;62(2):122\u201340. https:\/\/doi.org\/10.1111\/head.14259.","journal-title":"Headache Feb"},{"issue":"8","key":"4039_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache Sep. 2008;48(8):1157\u201368. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01217.x.","journal-title":"Headache Sep"},{"key":"4039_CR22","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. Jan 2018;38(1):1-211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"6","key":"4039_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1176\/appi.psy.50.6.613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosom Nov-Dec. 2009;50(6):613\u201321. https:\/\/doi.org\/10.1176\/appi.psy.50.6.613.","journal-title":"Psychosom Nov-Dec"},{"key":"4039_CR24","unstructured":"al Pe. Attitudes Towards Migraine by People Without Migraine: Results of the OVERCOME (EU) Study. 2022."},{"key":"4039_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cpr.2019.02.001","volume":"70","author":"PW Corrigan","year":"2019","unstructured":"Corrigan PW, Nieweglowski K. How does familiarity impact the stigma of mental illness? Clin Psychol Rev Jun. 2019;70:40\u201350. https:\/\/doi.org\/10.1016\/j.cpr.2019.02.001.","journal-title":"Clin Psychol Rev Jun"},{"issue":"9","key":"4039_CR26","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1007\/s10072-022-06178-6","volume":"43","author":"MF Rossi","year":"2022","unstructured":"Rossi MF, Tumminello A, Marconi M, et al. Sex and gender differences in migraines: a narrative review. Neurol Sci Sep. 2022;43(9):5729\u201334. https:\/\/doi.org\/10.1007\/s10072-022-06178-6.","journal-title":"Neurol Sci Sep"},{"issue":"8","key":"4039_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/jwh.2018.7274","volume":"27","author":"RA Schroeder","year":"2018","unstructured":"Schroeder RA, Brandes J, Buse DC, et al. Sex and gender differences in migraine-evaluating knowledge gaps. J Womens Health (Larchmt) Aug. 2018;27(8):965\u201373. https:\/\/doi.org\/10.1089\/jwh.2018.7274.","journal-title":"J Womens Health (Larchmt) Aug"},{"issue":"2","key":"4039_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.18553\/jmcp.2023.29.2.197","volume":"29","author":"RE Shapiro","year":"2023","unstructured":"Shapiro RE, Martin AA, Bhardwaj S, et al. Relationships between headache frequency, disability, and disability-related unemployment among adults with migraine. J Manag Care Spec Pharm Feb. 2023;29(2):197\u2013209. https:\/\/doi.org\/10.18553\/jmcp.2023.29.2.197.","journal-title":"J Manag Care Spec Pharm Feb"},{"issue":"3","key":"4039_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/10901981211011927","volume":"48","author":"UA Mitchell","year":"2021","unstructured":"Mitchell UA, Nishida A, Fletcher FE, Molina Y. The long arm of oppression: how structural stigma against marginalized communities perpetuates within-Group Health disparities. Health Educ Behav Jun. 2021;48(3):342\u201351. https:\/\/doi.org\/10.1177\/10901981211011927.","journal-title":"Health Educ Behav Jun"},{"key":"4039_CR30","doi-asserted-by":"publisher","unstructured":"Kobau R, Luncheon C, Greenlund K. May. Active epilepsy prevalence among U.S. adults is 1.1% and differs by educational level-National Health Interview Survey, United States, 2021. Epilepsy Behav. 2023;142:109180. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109180","DOI":"10.1016\/j.yebeh.2023.109180"},{"issue":"11","key":"4039_CR31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/acr.22890","volume":"68","author":"A Shmagel","year":"2016","unstructured":"Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back Pain in US adults: data from the 2009\u20132010 National Health and Nutrition Examination Survey. Arthritis Care Res (Hoboken) Nov. 2016;68(11):1688\u201394. https:\/\/doi.org\/10.1002\/acr.22890.","journal-title":"Arthritis Care Res (Hoboken) Nov"},{"issue":"6","key":"4039_CR32","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1007\/s10072-022-05888-1","volume":"43","author":"F Basoglu Koseahmet","year":"2022","unstructured":"Basoglu Koseahmet F, Polat B, Gozubatik-Celik RG, et al. An invisible cause of disability: stigma in migraine and epilepsy. Neurol Sci Jun. 2022;43(6):3831\u20138. https:\/\/doi.org\/10.1007\/s10072-022-05888-1.","journal-title":"Neurol Sci Jun"},{"key":"4039_CR33","doi-asserted-by":"crossref","unstructured":"Shapiro RE, Buse DC, Seng EK et al. A Multi-country comparison of Migraine Stigma in people living with migraine: results from the CaMEO - international study (P2-12.002). Neurology. 2023;102(17_supplement_1).","DOI":"10.1212\/WNL.0000000000206206"},{"key":"4039_CR34","doi-asserted-by":"publisher","DOI":"10.31234\/osf.io\/fs8ae","author":"M Granjon","year":"2023","unstructured":"Granjon M, Pillaud N, Popa-Roch M, Aube B, Rohmer O. The tip of the Iceberg. Uncovering Attitudes towards Invisible Disabil. 2023. https:\/\/doi.org\/10.31234\/osf.io\/fs8ae.","journal-title":"Uncovering Attitudes towards Invisible Disabil"},{"key":"4039_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/136843022312085","author":"M Granjon","year":"2023","unstructured":"Granjon M, Rohmer O, Popa-Roch M, Aube B, Sanrey C. Disability stereotyping is shaped by stigma characteristics. Group Processes Intergroup Relations. 2023. https:\/\/doi.org\/10.1177\/136843022312085.","journal-title":"Group Processes Intergroup Relations"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04039-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:15:46Z","timestamp":1741763746000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04039-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04039-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided electronic informed consent. This observational study was approved by the Sterling Institutional Review Board (IRB ID #6425-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Funding for this study was provided by Eli Lilly & Company. LV, EJM, AJZ, RAN: employees of Eli Lilly & Company. RES: consulting fees from Eli Lilly & Company, Theranica; travel or meeting support from Eli Lilly & Company; participation on monitoring or advisory board with Eli Lilly & Company; leadership or fiduciary role with Headache Cooperative of New England. DB: consulting fees from AbbVie, Biohaven, Collegium, Eli Lilly & Company, Lundbeck, Teva, Theranica; payment or honoraria from Lundbeck, Teva; participation on monitoring or advisory board with AbbVie, Eli Lilly & Company, Lundbeck, Teva. SA: consulting fees from AbbVie\/Allergan, Eli Lilly & Company, Lundbeck, Theranica, Linpharma, Satsuma, Pfizer; payment or honoraria from Teva, Eli Lilly & Company, Lundbeck; leadership or fiduciary role with Educational Committee of HIS, trustee of HIS board. SH: consulting fees from AbbVie, Amgen, Biohaven, Impel, Eli Lilly & Company, Lundbeck, Theranica, Upsher Smith; payment or honoraria from AbbVie, Biohaven, Impel, Eli Lilly & Company, Lundbeck, Teva, Theranica, Upsher Smith. RBL: grants or contracts from US Food & Drug Administration, Migraine Research Foundation, National Headache Foundation; royalties or licenses from Wolff\u2019s Headache 7th and 8th Edition, Oxford Press University, 2009, Wiley and Informa; consultant, advisory board member, or received honoraria from AbbVie (Allergan), American Academy of Neurology, American Headache Society, Amgen, Avanir, Axon, Axsome, Biohaven, Biovision, Boston Scientific, Dr. Reddy\u2019s (Promius), Electrocore, Eli Lilly & Company, eNeura Therapeutics, Equinox, GlaxoSmithKline, Grifols, Lundbeck (Alder), Manistee, Merck, Pernix, Pfizer, Satsuma, Supernus, Teva, Trigemina, Vector, Vedanta; stock or stock options from Axon, Biohaven Holdings, CoolTech, Manistee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}